IE45559L - ß-LACTAM COMPOUNDS - Google Patents
ß-LACTAM COMPOUNDSInfo
- Publication number
- IE45559L IE45559L IE771713A IE171377A IE45559L IE 45559 L IE45559 L IE 45559L IE 771713 A IE771713 A IE 771713A IE 171377 A IE171377 A IE 171377A IE 45559 L IE45559 L IE 45559L
- Authority
- IE
- Ireland
- Prior art keywords
- lactam compounds
- gram
- compounds
- gb1531141a
- penicillins
- Prior art date
Links
- -1 ß-LACTAM COMPOUNDS Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 108020004256 Beta-lactamase Proteins 0.000 abstract 1
- 229930186147 Cephalosporin Natural products 0.000 abstract 1
- 229930182555 Penicillin Natural products 0.000 abstract 1
- 102000006635 beta-lactamase Human genes 0.000 abstract 1
- 229940124587 cephalosporin Drugs 0.000 abstract 1
- 150000001780 cephalosporins Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002960 penicillins Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5456—Arylalkanephosphonium compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Salts of the compounds of the formula II are obtained by esterifying a salt of a corresponding 2-carboxylic acid. The products are antibacterially active and can increase the activity of penicillins and cephalosporins against ss-lactamase-producing strains of various Gram-positive and Gram-negative bacteria. <IMAGE>
[GB1531141A]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB34106/76A GB1531141A (en) | 1976-08-17 | 1976-08-17 | Beta-lactam antibiotics |
Publications (2)
Publication Number | Publication Date |
---|---|
IE45559L true IE45559L (en) | 1978-02-17 |
IE45559B1 IE45559B1 (en) | 1982-09-22 |
Family
ID=10361448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE1713/77A IE45559B1 (en) | 1976-08-17 | 1977-08-16 | Lactam antibiotics |
Country Status (19)
Country | Link |
---|---|
JP (1) | JPS5323995A (en) |
AT (1) | AT351678B (en) |
AU (1) | AU518375B2 (en) |
BE (1) | BE857781A (en) |
CA (1) | CA1104139A (en) |
CH (1) | CH639664A5 (en) |
DE (1) | DE2736482A1 (en) |
DK (1) | DK364177A (en) |
ES (1) | ES461691A1 (en) |
FI (1) | FI772432A (en) |
FR (2) | FR2362142A1 (en) |
GB (1) | GB1531141A (en) |
IE (1) | IE45559B1 (en) |
IL (1) | IL52638A (en) |
NL (1) | NL7709007A (en) |
NZ (1) | NZ184808A (en) |
PT (1) | PT66882B (en) |
SE (1) | SE7709071A0 (en) |
ZA (1) | ZA774703B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0002564B1 (en) * | 1977-11-12 | 1984-06-20 | Beecham Group Plc | Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates |
EP0004132A1 (en) * | 1978-03-04 | 1979-09-19 | Beecham Group Plc | Esters of beta-lactam antibiotics, a process for their preparation pharmaceutical compositions containing them and the compounds for use as antibacterial agents |
US4446146A (en) * | 1978-07-26 | 1984-05-01 | Beecham Group Limited | β-Lactam containing compounds, their preparation and use |
EP0007753B1 (en) * | 1978-08-02 | 1982-08-25 | Beecham Group Plc | Beta-lactam antibacterial agents, a process for their preparation and pharmaceutical compositions containing them |
US4530791A (en) * | 1979-04-16 | 1985-07-23 | Kowa Co., Ltd. | β-Lactam antibiotics |
DE3070269D1 (en) * | 1979-08-10 | 1985-04-18 | Beecham Group Plc | Beta-lactam antibiotics, their preparation, pharmaceutical compositions containing them and their preparation |
EP0044142A1 (en) * | 1980-07-03 | 1982-01-20 | Beecham Group Plc | Process for the preparation of beta-lactam antibiotics |
EP0057565A1 (en) * | 1981-02-04 | 1982-08-11 | Beecham Group Plc | Beta-lactam antibiotics, their preparation and use |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH633554A5 (en) * | 1975-11-21 | 1982-12-15 | Merck & Co Inc | Process for the preparation of novel thienamycin derivatives. |
-
1976
- 1976-08-17 GB GB34106/76A patent/GB1531141A/en not_active Expired
-
1977
- 1977-08-02 NZ NZ184808A patent/NZ184808A/en unknown
- 1977-08-02 IL IL52638A patent/IL52638A/en unknown
- 1977-08-03 PT PT66882A patent/PT66882B/en unknown
- 1977-08-04 ZA ZA00774703A patent/ZA774703B/en unknown
- 1977-08-10 SE SE7709071A patent/SE7709071A0/en not_active Application Discontinuation
- 1977-08-12 FI FI772432A patent/FI772432A/en not_active Application Discontinuation
- 1977-08-12 DE DE19772736482 patent/DE2736482A1/en not_active Withdrawn
- 1977-08-12 FR FR7724894A patent/FR2362142A1/en active Granted
- 1977-08-12 BE BE180166A patent/BE857781A/en not_active IP Right Cessation
- 1977-08-15 CH CH996577A patent/CH639664A5/en not_active IP Right Cessation
- 1977-08-16 IE IE1713/77A patent/IE45559B1/en unknown
- 1977-08-16 NL NL7709007A patent/NL7709007A/en not_active Application Discontinuation
- 1977-08-16 CA CA284,777A patent/CA1104139A/en not_active Expired
- 1977-08-16 AT AT592177A patent/AT351678B/en not_active IP Right Cessation
- 1977-08-16 DK DK364177A patent/DK364177A/en not_active Application Discontinuation
- 1977-08-17 AU AU27986/77A patent/AU518375B2/en not_active Expired
- 1977-08-17 JP JP9909877A patent/JPS5323995A/en active Pending
- 1977-08-17 ES ES461691A patent/ES461691A1/en not_active Expired
-
1978
- 1978-11-10 FR FR7831817A patent/FR2405260A1/en active Granted
Also Published As
Publication number | Publication date |
---|---|
AT351678B (en) | 1979-08-10 |
BE857781A (en) | 1978-02-13 |
ZA774703B (en) | 1978-06-28 |
ATA592177A (en) | 1979-01-15 |
AU2798677A (en) | 1979-02-22 |
IL52638A0 (en) | 1977-10-31 |
SE7709071L (en) | 1978-02-17 |
PT66882B (en) | 1979-01-24 |
CA1104139A (en) | 1981-06-30 |
NL7709007A (en) | 1978-02-21 |
CH639664A5 (en) | 1983-11-30 |
SE7709071A0 (en) | 1978-02-17 |
IE45559B1 (en) | 1982-09-22 |
FR2405260B1 (en) | 1980-10-31 |
FR2405260A1 (en) | 1979-05-04 |
FI772432A (en) | 1978-02-18 |
DK364177A (en) | 1978-02-18 |
PT66882A (en) | 1977-09-01 |
NZ184808A (en) | 1980-04-28 |
DE2736482A1 (en) | 1978-02-23 |
ES461691A1 (en) | 1978-06-01 |
IL52638A (en) | 1980-12-31 |
AU518375B2 (en) | 1981-10-01 |
FR2362142A1 (en) | 1978-03-17 |
JPS5323995A (en) | 1978-03-06 |
GB1531141A (en) | 1978-11-01 |
FR2362142B1 (en) | 1981-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE821129L (en) | Cephalosporins | |
IE45003L (en) | Oxiranylmethyltetrahydropyran derivatives | |
IE782546L (en) | Amino-thiazolyl cephalosporins | |
IE791041L (en) | Cephalosporin derivatives. | |
IE39549B1 (en) | Ureido-aryl cephalosporin compounds | |
IE45559L (en) | ß-LACTAM COMPOUNDS | |
AU520450B2 (en) | Oxime derivatives of 7-aminothiazolyl acetamido cephalosporanic acid | |
IE811811L (en) | Cephalosporins | |
IE44759L (en) | 1-aza-4-oxabicyclo [3,2,0] heptane derivatives | |
IE792208L (en) | Cephalosporin compounds. | |
IE44295L (en) | Preparation of clavulanic acid | |
ES442217A1 (en) | 1,4-Dihydro-4-oxo-pyridylacetamido cephalosporins and their utilization as medicinal agents for combating bacterial infections | |
JPS5214790A (en) | Process for preparing cephem or penam compounds | |
JPS5690088A (en) | Novel cephalosporin analog compound | |
IE43681L (en) | Penicillin compounds | |
IE45982L (en) | MONOCYCLIC ß-LACTAMS WITH ANTIBACTERIAL ACTIVITY. | |
IE802552L (en) | Cephalosporins. | |
IE810102L (en) | Penicillin compounds | |
ES8405016A1 (en) | Derivatives of clavulanic acid, their preparation and their use. | |
IE46100L (en) | Clavulanic acid derivatives | |
IE800882L (en) | Oxa-beta-lactam derivative | |
IE772501L (en) | Clavulanic acid ethers | |
IE782539L (en) | Penicillin derivatives | |
IE45686L (en) | 7-acylamino - 3 - (sulfomethylheterocyclic - thiomethyl)- 3¹- cephem -4- carboxylic acids. | |
IE45613L (en) | Cephalosporins. |